GLOBAL HORMONE REPLACEMENT THERAPY MARKET 2021-2028

Lifesciences | Healthcare & Wellness

GLOBAL HORMONE REPLACEMENT THERAPY MARKET 2021-2028

Market by Therapy Type, Type of Disease, Route of Administration, and Geography | Forecast 2021-2028

Request Free Sample

Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

Triton Market Research’s report on the global hormone replacement therapy market predicts that, based on revenue, the market is set to grow at a CAGR of 7.75% during the forecasting years 2021-2028. The market acquired revenue worth $17.44 billion in 2020, and is likely to garner $32.34 billion by 2028.


Report scope can be customized per your requirements. Request For Customization

Hormone replacement therapy replaces hormones such as testosterone, human growth, thyroid, estrogen, and progestogen that are at a lower level in the body.

The rising incidence of growth hormone-related disorders such as Prader-Willi syndrome is expected to drive the studied market’s growth. Prader-Willi disorder affects one in every 15,000 infants, thereby boosting the demand for growth hormone replacement therapy. Moreover, rising cases of osteoporosis due to hormonal imbalance during menopause and increasing prevalence of male hypogonadism are further expected to contribute towards the market’s growth. Other than this, an increase in growth deficiencies in the infant population over the past few years is anticipated to boost the hormone replacement market’s progress.

Triton’s study aims to get an overview of the hormone replacement therapy market in terms of various factors. Within this report, the key insight and the market summary regarding the market have been discussed. Also, the impact of COVID-19 on the market, Porter’s five forces model, market attractiveness matrix, vendor scorecard, and key market strategies have been studied in detail.

Major drivers like awareness pertaining to health problems during menopause and new product launches by major giants are driving the hormone replacement therapy market’s growth. Additionally, the availability of alternative therapy, coupled with the launch of telemedicine clinical practice services, are key elements offering growth opportunities to the reviewed market.

However, the high cost of treatment and adverse reactions related to hormone replacement therapy are obstructing the studied market’s development.



Key geographies covered in the hormone replacement therapy market are:

•           North America: Canada and United States

•           Europe: Russia, Spain, United Kingdom, Germany, France, Italy, and Rest of Europe

•           Asia-Pacific: Australia & New Zealand, Japan, India, ASEAN countries, South Korea, China, and Rest of Asia-Pacific

•           Latin America: Mexico, Brazil, and Rest of Latin America

•           Middle East and Africa: United Arab Emirates, Turkey, Saudi Arabia, South Africa, and Rest of Middle East & Africa

The market for hormone replacement therapy is segmented as follows:

•           Market by Therapy Type:

           o          Estrogen Hormone Replacement Therapy

           o          Thyroid Hormone Replacement Therapy

           o          Testosterone Hormone Replacement Therapy

           o          Human Growth Hormone Replacement Therapy

           o          Progestogen Hormone Replacement Therapy

•           Market by Type of Disease:

           o          Menopause

           o          Male Hypogonadism

           o          Growth Hormone Deficiency

           o          Hypothyroidism

           o          Other Type of Diseases

•           Market by Route of Administration:

           o          Oral

           o          Parenteral

           o          Transdermal

           o          Other Routes of Administration

The distinguished players engaged in the hormone replacement therapy market are Genentech Inc, Teva Pharmaceutical Industries Ltd, Amgen, Noven Pharmaceuticals Inc, Bayer AG, Viatris Inc (Mylan NV), Abbott Laboratories, Eli Lilly & Company, Merck KGAA, ANI Pharmaceuticals, Novartis AG, Novo Nordisk A/S, Dr Reddy’s Laboratories Ltd, Pfizer Inc, and Ipsen.

Related Reports

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027
Lifesciences

ASIA PACIFIC AESTHETIC LASER MARKET 2019-2027

Market By Type, Application, E ..

VIEW REPORT
ASIA PACIFIC BIOCHIPS MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOCHIPS MARKET 2019-2027

Market By Type, Substrate Mate ..

VIEW REPORT
ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027
Lifesciences

ASIA PACIFIC BIOPSY DEVICE MARKET 2019-2027

Market By Device Type, Therape ..

VIEW REPORT
ASIA PACIFIC DNA VACCINES MARKET 2019-2027
Lifesciences

ASIA PACIFIC DNA VACCINES MARKET 2019-2027

Market By Type, Application, T ..

VIEW REPORT
ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027
Lifesciences

ASIA-PACIFIC 3D CELL CULTURE MARKET 2019-2027

Market By Technology, Applicat ..

VIEW REPORT
ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028
Lifesciences

ASIA-PACIFIC AIRWAY CLEARANCE SYSTEM MARKET 2019-2028

Market By Application, Type, E ..

VIEW REPORT

Table of Content

1. GLOBAL HORMONE REPLACEMENT THERAPY MARKET - SUMMARY

2. INDUSTRY OUTLOOK

2.1. IMPACT OF COVID-19 ON HORMONE REPLACEMENT THERAPY MARKET

2.2. KEY INSIGHTS

2.2.1. INTRODUCTION OF NEW DRUG DELIVERY SYSTEMS FOR HORMONE REPLACEMENT

2.2.2. MODERN SEDENTARY LIFESTYLES

2.3. PORTER’S FIVE FORCES MODEL

2.3.1. THREAT OF NEW ENTRANTS

2.3.2. THREAT OF SUBSTITUTE PRODUCTS

2.3.3. BARGAINING POWER OF BUYERS

2.3.4. BARGAINING POWER OF SUPPLIERS

2.3.5. COMPETITIVE RIVALRY

2.4. MARKET ATTRACTIVENESS INDEX

2.5. VENDOR SCORECARD

2.6. KEY STRATEGIC DEVELOPMENTS

2.6.1. ACQUISITIONS & MERGERS

2.6.2. PRODUCT LAUNCH & DEVELOPMENTS

2.6.3. CONTRACTS AND PARTNERSHIPS

2.6.4. BUSINESS EXPANSIONS, ANNOUNCEMENTS, & DIVESTITURES

2.7. MARKET DRIVERS

2.7.1. RISE IN AWARENESS PERTAINING TO HEALTH PROBLEMS DURING MENOPAUSE

2.7.2. INCREASE IN PREVALENCE OF HORMONAL DISORDERS

2.7.3. NEW PRODUCT LAUNCHES BY MAJOR GIANTS

2.8. MARKET RESTRAINTS

2.8.1. HIGH COST OF TREATMENT

2.8.2. ADVERSE REACTIONS ASSOCIATED WITH HORMONE REPLACEMENT THERAPY

2.9. MARKET OPPORTUNITIES

2.9.1.   AVAILABILITY OF ALTERNATIVE THERAPY OFFERS OPPORTUNITIES FOR THE MARKET’S GROWTH

2.9.2.   LAUNCH OF TELEMEDICINE CLINICAL PRACTICE SERVICES

3. GLOBAL HORMONE REPLACEMENT THERAPY MARKET - BY THERAPY TYPE

3.1. ESTROGEN HORMONE REPLACEMENT THERAPY

3.2. THYROID HORMONE REPLACEMENT THERAPY

3.3. TESTOSTERONE HORMONE REPLACEMENT THERAPY

3.4. HUMAN GROWTH HORMONE REPLACEMENT THERAPY

3.5. PROGESTOGEN HORMONE REPLACEMENT THERAPY

4. GLOBAL HORMONE REPLACEMENT THERAPY MARKET - BY TYPE OF DISEASE

4.1. MENOPAUSE

4.2. MALE HYPOGONADISM

4.3. GROWTH HORMONE DEFICIENCY

4.4. HYPOTHYROIDISM

4.5. OTHER TYPE OF DISEASES

5. GLOBAL HORMONE REPLACEMENT THERAPY MARKET - BY ROUTE OF ADMINISTRATION

5.1. ORAL

5.2. PARENTERAL

5.3. TRANSDERMAL

5.4. OTHER ROUTES OF ADMINISTRATION

6. GLOBAL HORMONE REPLACEMENT THERAPY MARKET – REGIONAL OUTLOOK

6.1. NORTH AMERICA

6.1.1. MARKET BY THERAPY TYPE

6.1.2. MARKET BY TYPE OF DISEASE

6.1.3. MARKET BY ROUTE OF ADMINISTRATION

6.1.4. COUNTRY ANALYSIS

6.1.4.1. UNITED STATES

6.1.4.2. CANADA

6.2. EUROPE

6.2.1. MARKET BY THERAPY TYPE

6.2.2. MARKET BY TYPE OF DISEASE

6.2.3. MARKET BY ROUTE OF ADMINISTRATION

6.2.4. COUNTRY ANALYSIS

6.2.4.1. GERMANY

6.2.4.2. FRANCE

6.2.4.3. UNITED KINGDOM

6.2.4.4. ITALY

6.2.4.5. RUSSIA

6.2.4.6. SPAIN

6.2.4.7. REST OF EUROPE

6.3. ASIA-PACIFIC

6.3.1. MARKET BY THERAPY TYPE

6.3.2. MARKET BY TYPE OF DISEASE

6.3.3. MARKET BY ROUTE OF ADMINISTRATION

6.3.4. COUNTRY ANALYSIS

6.3.4.1. CHINA

6.3.4.2. JAPAN

6.3.4.3. INDIA

6.3.4.4. AUSTRALIA & NEW ZEALAND

6.3.4.5. SOUTH KOREA

6.3.4.6. ASEAN COUNTRIES

6.3.4.7. REST OF ASIA-PACIFIC

6.4. LATIN AMERICA

6.4.1. MARKET BY THERAPY TYPE

6.4.2. MARKET BY TYPE OF DISEASE

6.4.3. MARKET BY ROUTE OF ADMINISTRATION

6.4.4. COUNTRY ANALYSIS

6.4.4.1. MEXICO

6.4.4.2. BRAZIL

6.4.4.3. REST OF LATIN AMERICA

6.5. MIDDLE EAST AND AFRICA

6.5.1. MARKET BY THERAPY TYPE

6.5.2. MARKET BY TYPE OF DISEASE

6.5.3. MARKET BY ROUTE OF ADMINISTRATION

6.5.4. COUNTRY ANALYSIS

6.5.4.1. SAUDI ARABIA

6.5.4.2. UNITED ARAB EMIRATES

6.5.4.3. TURKEY

6.5.4.4. SOUTH AFRICA

6.5.4.5. REST OF MIDDLE EAST & AFRICA

7. COMPETITIVE LANDSCAPE

7.1. ABBOTT LABORATORIES

7.2. AMGEN

7.3. ANI PHARMACEUTICALS

7.4. BAYER AG

7.5. DR REDDY’S LABORATORIES LTD

7.6. ELI LILLY & COMPANY

7.7. GENENTECH INC

7.8. IPSEN

7.9. MERCK KGAA

7.10. NOVARTIS AG

7.11. NOVEN PHARMACEUTICALS INC

7.12. NOVO NORDISK A/S

7.13. PFIZER INC

7.14. TEVA PHARMACEUTICAL INDUSTRIES LTD

7.15. VIATRIS INC (MYLAN NV)

8. RESEARCH METHODOLOGY & SCOPE

8.1. RESEARCH SCOPE & DELIVERABLES

8.1.1. OBJECTIVES OF STUDY

8.1.2. SCOPE OF STUDY

8.2. SOURCES OF DATA

8.2.1. PRIMARY DATA SOURCES

8.2.2. SECONDARY DATA SOURCES

8.3. RESEARCH METHODOLOGY

8.3.1. EVALUATION OF PROPOSED MARKET

8.3.2. IDENTIFICATION OF DATA SOURCES

8.3.3. ASSESSMENT OF MARKET DETERMINANTS

8.3.4. DATA COLLECTION

8.3.5. DATA VALIDATION & ANALYSIS

List of Tables

TABLE 1:       GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 2:       VENDOR SCORECARD

TABLE 3:       LIST OF ACQUISITIONS & MERGERS

TABLE 4:       LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

TABLE 5:       LIST OF CONTRACTS AND PARTNERSHIPS

TABLE 6:       LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES

TABLE 7:       GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 8:       GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 9:       GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

TABLE 10:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY REGION, 2021-2028 (IN $ MILLION)

TABLE 11:     NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 12:     NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 13:     NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 14:     NORTH AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

TABLE 15:     EUROPE HORMONE REPLACEMENT THERAPY, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 16:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 17:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 18:     EUROPE HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

TABLE 19:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 20:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 21:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 22:     ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

TABLE 23:     LATIN AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 24:     LATIN AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 25:     LATIN AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 26:     LATIN AMERICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

TABLE 27:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY COUNTRY, 2021-2028 (IN $ MILLION)

TABLE 28:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2021-2028 (IN $ MILLION)

TABLE 29:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2021-2028 (IN $ MILLION)

TABLE 30:     MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

List of Figures

FIGURE 1:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 2:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THERAPY TYPE, 2020 & 2028 (IN %)

FIGURE 3:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ESTROGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 4:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY THYROID HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 5:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TESTOSTERONE HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 6:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY HUMAN GROWTH HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 7:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY PROGESTOGEN HORMONE REPLACEMENT THERAPY, 2021-2028 (IN $ MILLION)

FIGURE 8:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TYPE OF DISEASE, 2020 & 2028 (IN %)

FIGURE 9:     GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY MENOPAUSE, 2021-2028 (IN $ MILLION)

FIGURE 10:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY MALE HYPOGONADISM, 2021-2028 (IN $ MILLION)

FIGURE 11:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY GROWTH HORMONE DEFICIENCY, 2021-2028 (IN $ MILLION)

FIGURE 12:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY HYPOTHYROIDISM, 2021-2028 (IN $ MILLION)

FIGURE 13:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY OTHER TYPE OF DISEASES, 2021-2028 (IN $ MILLION)

FIGURE 14:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ROUTE OF ADMINISTRATION, 2020 & 2028 (IN %)

FIGURE 15:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY ORAL, 2021-2028 (IN $ MILLION)

FIGURE 16:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY PARENTERAL, 2021-2028 (IN $ MILLION)

FIGURE 17:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY TRANSDERMAL, 2021-2028 (IN $ MILLION)

FIGURE 18:  GLOBAL HORMONE REPLACEMENT THERAPY MARKET, BY OTHER ROUTES OF ADMINISTRATION, 2021-2028 (IN $ MILLION)

FIGURE 19:  UNITED STATES HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 20:  CANADA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 21:  GERMANY HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 22:  FRANCE HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 23:  UNITED KINGDOM HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 24:  ITALY HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 25:  RUSSIA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 26:  SPAIN HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 27:  REST OF EUROPE HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 28:  CHINA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 29:  JAPAN HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 30:  INDIA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 31:  AUSTRALIA & NEW ZEALAND HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 32:  SOUTH KOREA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 33:  ASEAN COUNTRIES HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 34:  REST OF ASIA-PACIFIC HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 35:  MEXICO HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 36:  BRAZIL HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 37:  REST OF LATIN AMERICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 38:  SAUDI ARABIA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 39:  UNITED ARAB EMIRATES HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 40:  TURKEY HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 41:  SOUTH AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

FIGURE 42:  REST OF MIDDLE EAST AND AFRICA HORMONE REPLACEMENT THERAPY MARKET 2021-2028 (IN $ MILLION)

Purchase Options

  • Licence Type
  • Price
  • User/Sharing
  • Printing
  • Delivery Formats
  • Free customization (Pre-sale)
  • Analyst hour support (Post Sale)
  • Customized notification for newly published report
  • Free report on update (within 180 days)

Single User PDF

$2,750.00

  • User/Sharing
  • Restricted to one authorized user
  • Printing
  • Not printable
  • Delivery Formats
  • Pdf
  • Free customization (Pre-sale)
  • 10% Free customization
  • Analyst hour support (Post Sale)
  • 3 hours
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Enterprise Online/PDF

$4,000.00

  • User/Sharing
  • Unlimited
  • Printing
  • Unlimited
  • Delivery Formats
  • Pdf and market estimation excel
  • Free customization (Pre-sale)
  • 20% Free customization
  • Analyst hour support (Post Sale)
  • 8 hour
  • Customized notification (newly published)
  • Free report on update (within 180 days)

Request free Sample

SUBMIT REQUEST
Request Custom Report

Request Custom Report

Enquire before buying

Enquire Before Buying

;